A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults

CompletedOBSERVATIONAL

Enrollment

10,673

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

HypopituitarismPituitary InsufficiencyGrowth Hormone Deficiency, Adult

Interventions

DRUG

Somatropin (rDNA origin)

Dose, frequency and duration are at discretion of attending physician, and determined on an individual basis.

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT01088399 - A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults | Biotech Hunter | Biotech Hunter